휴젤

145020KOSDAQ

58.6 / 100

Reference Date: 2026-09-08

Financial Score27.5 / 40

News Sentiment19.1 / 25

Momentum5.0 / 20

Disclosure7.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Declined 11.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Hujeel develops and manufactures biopharmaceuticals based on Clostridium botulinum type A toxin, and directly handles sales after merging with its subsidiary, Hujel Pharma, in 2018. Its major subsidiary, Acros, focuses on HA filler development and production. Both botulinum toxin and HA fillers have broad applications in medical and cosmetic fields.

Number of Employees

629people

Average Salary

64.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

18.61Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR

3.10Industry Average 1.200.0Point

2.6x industry avg (risky)

ROE

16.14Industry Average 8.007.0Point

2.0x industry avg (excellent)

Debt Ratio

0.37Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20259.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲15.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲31.0% (2-year basis)

ROE Trend

4.0 / 4

Avg ROE 15.3% (improving, 3yr)

Detailed News Sentiment

12 totalPositive 10Neutral 2Negative 0Average Sentiment Score 76.2

Positive
대웅·휴젤 나란히 1조…국산 톡신, 수출산업 됐다
휴젤의 북아메리카 매출이 두 배 증가하며 대웅제약과 함께 국산 톡신의 해외 시장 진출 성공을 보여주고 있다.
Neutral
1조 日 톡신 시장...대웅·메디톡스 정식 허가 속도 경쟁
기사는 대웅제약의 일본 톡신 승인 절차 시작을 다루지만, 휴젤(145020)에 직접적인 영향은 언급되지 않았습니다.
Positive
휴젤 코스메틱 '웰라쥬', 8년 연속 '올해의 브랜드' 1위
휴젤의 웰라쥬 브랜드가 더마 코스메틱 부문에서 8년 연속 최고 브랜드로 선정되어 긍정적인 시장 반응을 보임.

Detailed Momentum

52-week position3.0Point

52w lower range (23%)

Current 243,000Won52-week high 335,00052-week low 214,000

1-month return1.0Point

1m -11.15% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

8 totalPositive 0Neutral 7Negative 1

Neutral기업설명회(IR)개최2026-09-07
Neutral대규모기업집단현황공시[분기별공시(개별회사용)]2026-08-31
Neutral[기재정정]임시주주총회결과2026-08-24
Neutral임시주주총회결과2026-08-21
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-21